Emmanuel Stephen-Victor

Emmanuel Stephen-Victor

Auto-generated profile, based on publicly available information

Emmanuel Stephen-Victor

Division of Immunology, Boston Children’s Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Immunity
Verified
Journal Article
Closed access
JTJacob A. Turner
Jacob A. Turner
ESEmmanuel Stephen-Victor
Emmanuel Stephen-Victor
SWSen Wang
Sen Wang
MRMagali Noval Rivas
Magali Noval Rivas
AAAzza Abdel-Gadir
Azza Abdel-Gadir
TCTalal A. Chatila
Talal A. Chatila

1 June 2021 in Immunity
Verified
Journal Article
Closed access
Hani HarbHani Harb
Hani Harb
MBMehdi Benamar
Mehdi Benamar
PLPeggy S. Lai
Peggy S. Lai
PCPaola Contini
Paola Contini
JGJason W. Griffith
Jason W. Griffith
TCTalal A. Chatila
Talal A. Chatila

2 July 2020 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
ESEmmanuel Stephen-Victor
Emmanuel Stephen-Victor
MDMrinmoy Das
Mrinmoy Das
AKAnupama Karnam
Anupama Karnam
BPBruno Pitard
Bruno Pitard
JGJean-François Gautier
Jean-François Gautier
Jagadeesh BAYRYJagadeesh BAYRY
Jagadeesh BAYRY
In view of dysregulated immune response, “cytokine storm” and inflammation-induced lung damage in severely ill COVID-19 patients, we propose that CD4+CD25+FoxP3+ regulatory T-cell-based therapies could be considered for patient managementhttps://bit.ly/3eKqWPo

4 May 2018 in Science Immunology
Verified
Journal Article
Closed access
PDF file
MSMeenu Sharma
Meenu Sharma
MDMrinmoy Das
Mrinmoy Das
ESEmmanuel Stephen-Victor
Emmanuel Stephen-Victor
CGCaroline Galeotti
Caroline Galeotti
AKAnupama Karnam
Anupama Karnam
Jagadeesh BAYRYJagadeesh BAYRY
Jagadeesh BAYRY
Human basophils are refractory to suppression by T regs and undergo activation by an IL-3– and STAT5-dependent mechanism.

22 January 2025 in Nature
Verified
Journal Article
Closed access
PDF file
ESEmmanuel Stephen-Victor
Emmanuel Stephen-Victor
GKGavin A. Kuziel
Gavin A. Kuziel
MMMonica Martinez-Blanco
Monica Martinez-Blanco
BJBat-Erdene Jugder
Bat-Erdene Jugder
MBMehdi Benamar
Mehdi Benamar
TCTalal A. Chatila
Talal A. Chatila

30 September 2022 in Science Immunology
Verified
Journal Article
Open access
YCYe Cui
Ye Cui
MBMehdi Benamar
Mehdi Benamar
KSKlaus Schmitz-Abe
Klaus Schmitz-Abe
VPVarsha Poondi-Krishnan
Varsha Poondi-Krishnan
QCQian Chen
Qian Chen
TCTalal A. Chatila
Talal A. Chatila
The molecular programs involved in regulatory T (T reg ) cell activation and homeostasis remain incompletely understood. Here, we show that T cell receptor (TCR) signaling in T reg cells induces the nuclear translocation of serine/threonine kinase 4 (Stk4), leading to the formation of an Stk4–NF-κB p65–Foxp3 complex that regulates Foxp3- and p65-dependent transcriptional programs. This complex was stabilized by Stk4-dependent phosphorylation of Foxp3 on serine-418. Stk4 deficiency in T reg cells, either alone or in combination with its homolog Stk3, precipitated a fatal autoimmune lymphoproliferative disease in mice characterized by decreased T reg cell p65 expression and nuclear translocation, impaired NF-κB p65–Foxp3 complex formation, and defective T reg cell activation. In an adoptive immunotherapy model, overexpression of p65 or the phosphomimetic Foxp3 S418E in Stk3/4-deficient T reg cells ameliorated their immune regulatory defects. Our studies identify Stk4 as an essential TCR-responsive regulator of p65-Foxp3–dependent transcription that promotes T reg cell–mediated immune tolerance.